Careers  |  Sign In  |  Register  |   Twitter

Latest in Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Pomalidomide-Dexamethasone Beneficial in Refractory Multiple Myeloma

NEW YORK (Reuters Health) – The combination of pomalidomide and low-dose dexamethasone improves survival in patients with advanced multiple myeloma more than does treatment with high-dose dexamethasone alone, a multinational study has shown. “Pomalidomide plus low-dose dexamethasone, an oral regimen,...

Reuters Health • The Doctor's Channel Daily Newscast

Amino Acid Transporters a Promising Target in Metastatic Prostate Cancer

NEW YORK (Reuters Health) – Australian and Canadian researchers have shown in lab experiments that L-type amino acid transporters (LATS) are crucial to the growth and proliferation of castration-resistant prostate cancer (CRPC) cells. “Targeting LAT transporters, thereby inhibiting leucine uptake, may...
A new front page article in The New York Times reports that papers published in two medical journals "prompted medical historians to denounce” a study that took place in the 1950s involving Manhattan “skid row alcoholics.” Participants in the study were told that “if they agreed to surgical biopsies...